nodes	percent_of_prediction	percent_of_DWPC	metapath
Ofloxacin—SLC22A5—dilated cardiomyopathy	0.507	1	CbGaD
Ofloxacin—ABCC2—Spironolactone—dilated cardiomyopathy	0.12	0.327	CbGbCtD
Ofloxacin—SLC22A5—Furosemide—dilated cardiomyopathy	0.105	0.287	CbGbCtD
Ofloxacin—ABCC2—Furosemide—dilated cardiomyopathy	0.0819	0.223	CbGbCtD
Ofloxacin—SLC22A6—Furosemide—dilated cardiomyopathy	0.0599	0.163	CbGbCtD
Ofloxacin—SLC22A4—Organic cation transport—SLC22A5—dilated cardiomyopathy	0.00337	0.244	CbGpPWpGaD
Ofloxacin—SLC22A4—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.00229	0.166	CbGpPWpGaD
Ofloxacin—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.0013	0.0939	CbGpPWpGaD
Ofloxacin—Sparfloxacin—SLC22A5—dilated cardiomyopathy	0.0013	0.418	CrCbGaD
Ofloxacin—TOP2A—Methyltestosterone—Spironolactone—dilated cardiomyopathy	0.00121	1	CbGdCrCtD
Ofloxacin—Lomefloxacin—SLC22A5—dilated cardiomyopathy	0.00107	0.344	CrCbGaD
Ofloxacin—Norfloxacin—SLC22A5—dilated cardiomyopathy	0.00074	0.238	CrCbGaD
Ofloxacin—ABCC2—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.000517	0.0374	CbGpPWpGaD
Ofloxacin—ABCC1—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.000511	0.037	CbGpPWpGaD
Ofloxacin—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.000458	0.0332	CbGpPWpGaD
Ofloxacin—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.000432	0.00399	CcSEcCtD
Ofloxacin—Creatinine increased—Lisinopril—dilated cardiomyopathy	0.000426	0.00394	CcSEcCtD
Ofloxacin—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.000418	0.00386	CcSEcCtD
Ofloxacin—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.000416	0.00384	CcSEcCtD
Ofloxacin—Vasculitis—Lisinopril—dilated cardiomyopathy	0.000416	0.00384	CcSEcCtD
Ofloxacin—Thirst—Furosemide—dilated cardiomyopathy	0.000412	0.00381	CcSEcCtD
Ofloxacin—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.000411	0.00379	CcSEcCtD
Ofloxacin—Purpura—Furosemide—dilated cardiomyopathy	0.000407	0.00376	CcSEcCtD
Ofloxacin—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.000406	0.00375	CcSEcCtD
Ofloxacin—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.000406	0.00375	CcSEcCtD
Ofloxacin—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.000405	0.00375	CcSEcCtD
Ofloxacin—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.000403	0.00372	CcSEcCtD
Ofloxacin—Hyperkalaemia—Lisinopril—dilated cardiomyopathy	0.000399	0.00368	CcSEcCtD
Ofloxacin—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.000394	0.00364	CcSEcCtD
Ofloxacin—Influenza like illness—Lisinopril—dilated cardiomyopathy	0.000394	0.00364	CcSEcCtD
Ofloxacin—Malaise—Spironolactone—dilated cardiomyopathy	0.000392	0.00362	CcSEcCtD
Ofloxacin—Cystitis—Lisinopril—dilated cardiomyopathy	0.000392	0.00362	CcSEcCtD
Ofloxacin—Leukopenia—Spironolactone—dilated cardiomyopathy	0.000389	0.00359	CcSEcCtD
Ofloxacin—Blood urea increased—Lisinopril—dilated cardiomyopathy	0.000383	0.00354	CcSEcCtD
Ofloxacin—TOP2A—Circadian rythm related genes—SIK1—dilated cardiomyopathy	0.000382	0.0277	CbGpPWpGaD
Ofloxacin—Photophobia—Lisinopril—dilated cardiomyopathy	0.000381	0.00352	CcSEcCtD
Ofloxacin—Neuropathy—Lisinopril—dilated cardiomyopathy	0.000381	0.00352	CcSEcCtD
Ofloxacin—Urinary retention—Furosemide—dilated cardiomyopathy	0.000373	0.00345	CcSEcCtD
Ofloxacin—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.000368	0.0034	CcSEcCtD
Ofloxacin—Discomfort—Spironolactone—dilated cardiomyopathy	0.000365	0.00338	CcSEcCtD
Ofloxacin—Dehydration—Furosemide—dilated cardiomyopathy	0.000365	0.00337	CcSEcCtD
Ofloxacin—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.000363	0.00335	CcSEcCtD
Ofloxacin—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.000361	0.00334	CcSEcCtD
Ofloxacin—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.000358	0.00331	CcSEcCtD
Ofloxacin—Confusional state—Spironolactone—dilated cardiomyopathy	0.000357	0.0033	CcSEcCtD
Ofloxacin—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.000357	0.0033	CcSEcCtD
Ofloxacin—Hypertonia—Lisinopril—dilated cardiomyopathy	0.000356	0.00329	CcSEcCtD
Ofloxacin—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.000355	0.00328	CcSEcCtD
Ofloxacin—Cramp muscle—Furosemide—dilated cardiomyopathy	0.000353	0.00327	CcSEcCtD
Ofloxacin—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.000353	0.00327	CcSEcCtD
Ofloxacin—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.000347	0.00321	CcSEcCtD
Ofloxacin—Abdominal distension—Furosemide—dilated cardiomyopathy	0.000341	0.00316	CcSEcCtD
Ofloxacin—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.00034	0.00314	CcSEcCtD
Ofloxacin—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.000339	0.00313	CcSEcCtD
Ofloxacin—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.000337	0.00311	CcSEcCtD
Ofloxacin—Eosinophilia—Furosemide—dilated cardiomyopathy	0.000336	0.0031	CcSEcCtD
Ofloxacin—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.000335	0.0031	CcSEcCtD
Ofloxacin—Pancreatitis—Furosemide—dilated cardiomyopathy	0.000333	0.00307	CcSEcCtD
Ofloxacin—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.000332	0.00307	CcSEcCtD
Ofloxacin—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.000328	0.00303	CcSEcCtD
Ofloxacin—Eczema—Lisinopril—dilated cardiomyopathy	0.000328	0.00303	CcSEcCtD
Ofloxacin—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.000326	0.00301	CcSEcCtD
Ofloxacin—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.000319	0.00295	CcSEcCtD
Ofloxacin—Somnolence—Spironolactone—dilated cardiomyopathy	0.000315	0.00291	CcSEcCtD
Ofloxacin—Pollakiuria—Furosemide—dilated cardiomyopathy	0.000313	0.0029	CcSEcCtD
Ofloxacin—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.000311	0.00287	CcSEcCtD
Ofloxacin—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00031	0.00286	CcSEcCtD
Ofloxacin—Renal impairment—Lisinopril—dilated cardiomyopathy	0.000309	0.00286	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000306	0.00283	CcSEcCtD
Ofloxacin—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.000306	0.00283	CcSEcCtD
Ofloxacin—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.000304	0.00281	CcSEcCtD
Ofloxacin—Arthritis—Lisinopril—dilated cardiomyopathy	0.000303	0.0028	CcSEcCtD
Ofloxacin—Drowsiness—Furosemide—dilated cardiomyopathy	0.000302	0.00279	CcSEcCtD
Ofloxacin—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.000302	0.00279	CcSEcCtD
Ofloxacin—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.0003	0.00278	CcSEcCtD
Ofloxacin—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.0003	0.00277	CcSEcCtD
Ofloxacin—Renal failure—Furosemide—dilated cardiomyopathy	0.000297	0.00275	CcSEcCtD
Ofloxacin—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.000296	0.00273	CcSEcCtD
Ofloxacin—Diplopia—Lisinopril—dilated cardiomyopathy	0.000294	0.00272	CcSEcCtD
Ofloxacin—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.000294	0.00272	CcSEcCtD
Ofloxacin—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.000294	0.00272	CcSEcCtD
Ofloxacin—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000292	0.0027	CcSEcCtD
Ofloxacin—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.000286	0.00264	CcSEcCtD
Ofloxacin—Face oedema—Lisinopril—dilated cardiomyopathy	0.000284	0.00263	CcSEcCtD
Ofloxacin—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.000282	0.00261	CcSEcCtD
Ofloxacin—Urticaria—Spironolactone—dilated cardiomyopathy	0.000282	0.0026	CcSEcCtD
Ofloxacin—ABCC1—S1P1 pathway—RAC1—dilated cardiomyopathy	0.00028	0.0203	CbGpPWpGaD
Ofloxacin—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00028	0.00259	CcSEcCtD
Ofloxacin—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.00028	0.00259	CcSEcCtD
Ofloxacin—Ataxia—Lisinopril—dilated cardiomyopathy	0.000277	0.00256	CcSEcCtD
Ofloxacin—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.000276	0.00255	CcSEcCtD
Ofloxacin—Dehydration—Lisinopril—dilated cardiomyopathy	0.000274	0.00253	CcSEcCtD
Ofloxacin—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.000269	0.00249	CcSEcCtD
Ofloxacin—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.000268	0.00248	CcSEcCtD
Ofloxacin—Urethral disorder—Furosemide—dilated cardiomyopathy	0.000266	0.00246	CcSEcCtD
Ofloxacin—Breast disorder—Lisinopril—dilated cardiomyopathy	0.000266	0.00246	CcSEcCtD
Ofloxacin—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.000265	0.00245	CcSEcCtD
Ofloxacin—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.000265	0.00245	CcSEcCtD
Ofloxacin—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.000263	0.00243	CcSEcCtD
Ofloxacin—Visual impairment—Furosemide—dilated cardiomyopathy	0.000262	0.00242	CcSEcCtD
Ofloxacin—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000261	0.00241	CcSEcCtD
Ofloxacin—Gastritis—Lisinopril—dilated cardiomyopathy	0.000261	0.00241	CcSEcCtD
Ofloxacin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.00026	0.0188	CbGpPWpGaD
Ofloxacin—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.000257	0.00237	CcSEcCtD
Ofloxacin—Asthma—Lisinopril—dilated cardiomyopathy	0.000254	0.00235	CcSEcCtD
Ofloxacin—Eye disorder—Furosemide—dilated cardiomyopathy	0.000254	0.00234	CcSEcCtD
Ofloxacin—Tinnitus—Furosemide—dilated cardiomyopathy	0.000253	0.00234	CcSEcCtD
Ofloxacin—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.000252	0.00233	CcSEcCtD
Ofloxacin—Pruritus—Spironolactone—dilated cardiomyopathy	0.000251	0.00232	CcSEcCtD
Ofloxacin—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.00025	0.00231	CcSEcCtD
Ofloxacin—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.000249	0.00231	CcSEcCtD
Ofloxacin—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.000248	0.00229	CcSEcCtD
Ofloxacin—Sweating increased—Lisinopril—dilated cardiomyopathy	0.000248	0.00229	CcSEcCtD
Ofloxacin—Angiopathy—Furosemide—dilated cardiomyopathy	0.000246	0.00228	CcSEcCtD
Ofloxacin—Immune system disorder—Furosemide—dilated cardiomyopathy	0.000245	0.00227	CcSEcCtD
Ofloxacin—Bronchitis—Lisinopril—dilated cardiomyopathy	0.000245	0.00226	CcSEcCtD
Ofloxacin—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000243	0.00224	CcSEcCtD
Ofloxacin—Arrhythmia—Furosemide—dilated cardiomyopathy	0.000243	0.00224	CcSEcCtD
Ofloxacin—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.000242	0.00223	CcSEcCtD
Ofloxacin—Neutropenia—Lisinopril—dilated cardiomyopathy	0.000238	0.0022	CcSEcCtD
Ofloxacin—Dysuria—Lisinopril—dilated cardiomyopathy	0.000238	0.0022	CcSEcCtD
Ofloxacin—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.000237	0.00219	CcSEcCtD
Ofloxacin—Erythema—Furosemide—dilated cardiomyopathy	0.000236	0.00218	CcSEcCtD
Ofloxacin—Malnutrition—Furosemide—dilated cardiomyopathy	0.000236	0.00218	CcSEcCtD
Ofloxacin—Dizziness—Spironolactone—dilated cardiomyopathy	0.000234	0.00217	CcSEcCtD
Ofloxacin—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.000234	0.00217	CcSEcCtD
Ofloxacin—Flatulence—Furosemide—dilated cardiomyopathy	0.000233	0.00215	CcSEcCtD
Ofloxacin—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.000232	0.00215	CcSEcCtD
Ofloxacin—Dysgeusia—Furosemide—dilated cardiomyopathy	0.000231	0.00214	CcSEcCtD
Ofloxacin—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00023	0.00213	CcSEcCtD
Ofloxacin—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00023	0.00212	CcSEcCtD
Ofloxacin—Pneumonia—Lisinopril—dilated cardiomyopathy	0.000228	0.00211	CcSEcCtD
Ofloxacin—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000227	0.0021	CcSEcCtD
Ofloxacin—Vomiting—Spironolactone—dilated cardiomyopathy	0.000225	0.00208	CcSEcCtD
Ofloxacin—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.000225	0.00208	CcSEcCtD
Ofloxacin—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.000224	0.00207	CcSEcCtD
Ofloxacin—Rash—Spironolactone—dilated cardiomyopathy	0.000224	0.00207	CcSEcCtD
Ofloxacin—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000223	0.00206	CcSEcCtD
Ofloxacin—Renal failure—Lisinopril—dilated cardiomyopathy	0.000223	0.00206	CcSEcCtD
Ofloxacin—Vision blurred—Furosemide—dilated cardiomyopathy	0.000223	0.00206	CcSEcCtD
Ofloxacin—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.000222	0.00206	CcSEcCtD
Ofloxacin—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.000222	0.00206	CcSEcCtD
Ofloxacin—Headache—Spironolactone—dilated cardiomyopathy	0.000222	0.00205	CcSEcCtD
Ofloxacin—Jaundice—Lisinopril—dilated cardiomyopathy	0.000221	0.00204	CcSEcCtD
Ofloxacin—Anaemia—Furosemide—dilated cardiomyopathy	0.000218	0.00202	CcSEcCtD
Ofloxacin—Agitation—Furosemide—dilated cardiomyopathy	0.000217	0.00201	CcSEcCtD
Ofloxacin—Haematuria—Lisinopril—dilated cardiomyopathy	0.000216	0.002	CcSEcCtD
Ofloxacin—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.000215	0.00198	CcSEcCtD
Ofloxacin—Epistaxis—Lisinopril—dilated cardiomyopathy	0.000214	0.00198	CcSEcCtD
Ofloxacin—Sinusitis—Lisinopril—dilated cardiomyopathy	0.000213	0.00197	CcSEcCtD
Ofloxacin—Vertigo—Furosemide—dilated cardiomyopathy	0.000212	0.00196	CcSEcCtD
Ofloxacin—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.000212	0.00196	CcSEcCtD
Ofloxacin—Leukopenia—Furosemide—dilated cardiomyopathy	0.000212	0.00195	CcSEcCtD
Ofloxacin—Nausea—Spironolactone—dilated cardiomyopathy	0.000211	0.00195	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000209	0.0151	CbGpPWpGaD
Ofloxacin—SLC22A4—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000208	0.0151	CbGpPWpGaD
Ofloxacin—Bradycardia—Lisinopril—dilated cardiomyopathy	0.000207	0.00192	CcSEcCtD
Ofloxacin—Rhinitis—Lisinopril—dilated cardiomyopathy	0.000204	0.00189	CcSEcCtD
Ofloxacin—Hepatitis—Lisinopril—dilated cardiomyopathy	0.000204	0.00188	CcSEcCtD
Ofloxacin—Hallucination—Lisinopril—dilated cardiomyopathy	0.000203	0.00187	CcSEcCtD
Ofloxacin—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.000202	0.00187	CcSEcCtD
Ofloxacin—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.000201	0.00186	CcSEcCtD
Ofloxacin—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.000201	0.00185	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.0002	0.00185	CcSEcCtD
Ofloxacin—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.0002	0.00185	CcSEcCtD
Ofloxacin—Dry mouth—Furosemide—dilated cardiomyopathy	0.000197	0.00182	CcSEcCtD
Ofloxacin—Confusional state—Furosemide—dilated cardiomyopathy	0.000194	0.0018	CcSEcCtD
Ofloxacin—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000193	0.00178	CcSEcCtD
Ofloxacin—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.000193	0.00178	CcSEcCtD
Ofloxacin—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00019	0.00176	CcSEcCtD
Ofloxacin—Shock—Furosemide—dilated cardiomyopathy	0.00019	0.00175	CcSEcCtD
Ofloxacin—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000189	0.00175	CcSEcCtD
Ofloxacin—Flushing—Lisinopril—dilated cardiomyopathy	0.000189	0.00175	CcSEcCtD
Ofloxacin—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000189	0.00175	CcSEcCtD
Ofloxacin—Skin disorder—Furosemide—dilated cardiomyopathy	0.000187	0.00173	CcSEcCtD
Ofloxacin—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000186	0.00172	CcSEcCtD
Ofloxacin—Angiopathy—Lisinopril—dilated cardiomyopathy	0.000185	0.00171	CcSEcCtD
Ofloxacin—Anorexia—Furosemide—dilated cardiomyopathy	0.000184	0.0017	CcSEcCtD
Ofloxacin—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.000184	0.0017	CcSEcCtD
Ofloxacin—Chills—Lisinopril—dilated cardiomyopathy	0.000183	0.00169	CcSEcCtD
Ofloxacin—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000182	0.00168	CcSEcCtD
Ofloxacin—Hypotension—Furosemide—dilated cardiomyopathy	0.00018	0.00167	CcSEcCtD
Ofloxacin—Alopecia—Lisinopril—dilated cardiomyopathy	0.00018	0.00166	CcSEcCtD
Ofloxacin—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000178	0.00165	CcSEcCtD
Ofloxacin—Erythema—Lisinopril—dilated cardiomyopathy	0.000177	0.00164	CcSEcCtD
Ofloxacin—Malnutrition—Lisinopril—dilated cardiomyopathy	0.000177	0.00164	CcSEcCtD
Ofloxacin—Flatulence—Lisinopril—dilated cardiomyopathy	0.000175	0.00161	CcSEcCtD
Ofloxacin—Tension—Lisinopril—dilated cardiomyopathy	0.000174	0.00161	CcSEcCtD
Ofloxacin—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000174	0.0016	CcSEcCtD
Ofloxacin—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000173	0.0016	CcSEcCtD
Ofloxacin—Nervousness—Lisinopril—dilated cardiomyopathy	0.000172	0.00159	CcSEcCtD
Ofloxacin—Back pain—Lisinopril—dilated cardiomyopathy	0.000172	0.00159	CcSEcCtD
Ofloxacin—Somnolence—Furosemide—dilated cardiomyopathy	0.000171	0.00158	CcSEcCtD
Ofloxacin—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00017	0.00158	CcSEcCtD
Ofloxacin—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000168	0.00155	CcSEcCtD
Ofloxacin—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000167	0.00154	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000167	0.00154	CcSEcCtD
Ofloxacin—Fatigue—Furosemide—dilated cardiomyopathy	0.000166	0.00154	CcSEcCtD
Ofloxacin—Tremor—Lisinopril—dilated cardiomyopathy	0.000166	0.00154	CcSEcCtD
Ofloxacin—Constipation—Furosemide—dilated cardiomyopathy	0.000165	0.00152	CcSEcCtD
Ofloxacin—Pain—Furosemide—dilated cardiomyopathy	0.000165	0.00152	CcSEcCtD
Ofloxacin—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000165	0.00152	CcSEcCtD
Ofloxacin—Anaemia—Lisinopril—dilated cardiomyopathy	0.000164	0.00151	CcSEcCtD
Ofloxacin—Angioedema—Lisinopril—dilated cardiomyopathy	0.000162	0.0015	CcSEcCtD
Ofloxacin—Malaise—Lisinopril—dilated cardiomyopathy	0.00016	0.00148	CcSEcCtD
Ofloxacin—Vertigo—Lisinopril—dilated cardiomyopathy	0.000159	0.00147	CcSEcCtD
Ofloxacin—Syncope—Lisinopril—dilated cardiomyopathy	0.000159	0.00147	CcSEcCtD
Ofloxacin—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000159	0.00147	CcSEcCtD
Ofloxacin—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000159	0.00147	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000158	0.00146	CcSEcCtD
Ofloxacin—Palpitations—Lisinopril—dilated cardiomyopathy	0.000157	0.00145	CcSEcCtD
Ofloxacin—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000156	0.00144	CcSEcCtD
Ofloxacin—Cough—Lisinopril—dilated cardiomyopathy	0.000155	0.00143	CcSEcCtD
Ofloxacin—Urticaria—Furosemide—dilated cardiomyopathy	0.000153	0.00142	CcSEcCtD
Ofloxacin—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000152	0.00141	CcSEcCtD
Ofloxacin—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000152	0.00141	CcSEcCtD
Ofloxacin—Chest pain—Lisinopril—dilated cardiomyopathy	0.000151	0.0014	CcSEcCtD
Ofloxacin—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000151	0.0014	CcSEcCtD
Ofloxacin—Myalgia—Lisinopril—dilated cardiomyopathy	0.000151	0.0014	CcSEcCtD
Ofloxacin—Anxiety—Lisinopril—dilated cardiomyopathy	0.00015	0.00139	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00015	0.00139	CcSEcCtD
Ofloxacin—Discomfort—Lisinopril—dilated cardiomyopathy	0.000149	0.00138	CcSEcCtD
Ofloxacin—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000148	0.00136	CcSEcCtD
Ofloxacin—Confusional state—Lisinopril—dilated cardiomyopathy	0.000146	0.00135	CcSEcCtD
Ofloxacin—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000145	0.00134	CcSEcCtD
Ofloxacin—Oedema—Lisinopril—dilated cardiomyopathy	0.000145	0.00134	CcSEcCtD
Ofloxacin—Infection—Lisinopril—dilated cardiomyopathy	0.000144	0.00133	CcSEcCtD
Ofloxacin—Shock—Lisinopril—dilated cardiomyopathy	0.000142	0.00132	CcSEcCtD
Ofloxacin—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000142	0.00131	CcSEcCtD
Ofloxacin—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000142	0.00131	CcSEcCtD
Ofloxacin—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000141	0.00131	CcSEcCtD
Ofloxacin—ABCC1—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000141	0.0102	CbGpPWpGaD
Ofloxacin—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000141	0.0013	CcSEcCtD
Ofloxacin—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00014	0.00129	CcSEcCtD
Ofloxacin—Asthenia—Furosemide—dilated cardiomyopathy	0.000138	0.00128	CcSEcCtD
Ofloxacin—Anorexia—Lisinopril—dilated cardiomyopathy	0.000138	0.00127	CcSEcCtD
Ofloxacin—Pruritus—Furosemide—dilated cardiomyopathy	0.000136	0.00126	CcSEcCtD
Ofloxacin—Hypotension—Lisinopril—dilated cardiomyopathy	0.000135	0.00125	CcSEcCtD
Ofloxacin—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000132	0.00122	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000132	0.00122	CcSEcCtD
Ofloxacin—Insomnia—Lisinopril—dilated cardiomyopathy	0.000131	0.00121	CcSEcCtD
Ofloxacin—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00013	0.0012	CcSEcCtD
Ofloxacin—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000129	0.00119	CcSEcCtD
Ofloxacin—Somnolence—Lisinopril—dilated cardiomyopathy	0.000129	0.00119	CcSEcCtD
Ofloxacin—Dizziness—Furosemide—dilated cardiomyopathy	0.000128	0.00118	CcSEcCtD
Ofloxacin—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000127	0.00118	CcSEcCtD
Ofloxacin—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000126	0.00116	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000125	0.00115	CcSEcCtD
Ofloxacin—Fatigue—Lisinopril—dilated cardiomyopathy	0.000125	0.00115	CcSEcCtD
Ofloxacin—TOP2A—Gastric Cancer Network 2—EGFR—dilated cardiomyopathy	0.000124	0.00902	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—TUBB—dilated cardiomyopathy	0.000124	0.00899	CbGpPWpGaD
Ofloxacin—Pain—Lisinopril—dilated cardiomyopathy	0.000124	0.00114	CcSEcCtD
Ofloxacin—Constipation—Lisinopril—dilated cardiomyopathy	0.000124	0.00114	CcSEcCtD
Ofloxacin—Vomiting—Furosemide—dilated cardiomyopathy	0.000123	0.00113	CcSEcCtD
Ofloxacin—Rash—Furosemide—dilated cardiomyopathy	0.000122	0.00112	CcSEcCtD
Ofloxacin—Dermatitis—Furosemide—dilated cardiomyopathy	0.000121	0.00112	CcSEcCtD
Ofloxacin—Headache—Furosemide—dilated cardiomyopathy	0.000121	0.00112	CcSEcCtD
Ofloxacin—CYP1A2—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000121	0.00874	CbGpPWpGaD
Ofloxacin—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000119	0.0011	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000118	0.00109	CcSEcCtD
Ofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000118	0.00855	CbGpPWpGaD
Ofloxacin—Urticaria—Lisinopril—dilated cardiomyopathy	0.000115	0.00106	CcSEcCtD
Ofloxacin—Nausea—Furosemide—dilated cardiomyopathy	0.000115	0.00106	CcSEcCtD
Ofloxacin—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000114	0.00106	CcSEcCtD
Ofloxacin—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000114	0.00106	CcSEcCtD
Ofloxacin—TOP2A—Cell Cycle—TUBB—dilated cardiomyopathy	0.000111	0.00804	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—EMD—dilated cardiomyopathy	0.000111	0.00801	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000109	0.00787	CbGpPWpGaD
Ofloxacin—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000107	0.000985	CcSEcCtD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000106	0.00766	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000106	0.00766	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—ALMS1—dilated cardiomyopathy	0.000104	0.00753	CbGpPWpGaD
Ofloxacin—Asthenia—Lisinopril—dilated cardiomyopathy	0.000104	0.00096	CcSEcCtD
Ofloxacin—Pruritus—Lisinopril—dilated cardiomyopathy	0.000102	0.000946	CcSEcCtD
Ofloxacin—Diarrhoea—Lisinopril—dilated cardiomyopathy	9.9e-05	0.000915	CcSEcCtD
Ofloxacin—TOP2A—Cell Cycle—EMD—dilated cardiomyopathy	9.89e-05	0.00716	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	9.83e-05	0.00712	CbGpPWpGaD
Ofloxacin—Dizziness—Lisinopril—dilated cardiomyopathy	9.57e-05	0.000884	CcSEcCtD
Ofloxacin—TOP2A—Cell Cycle—ALMS1—dilated cardiomyopathy	9.3e-05	0.00674	CbGpPWpGaD
Ofloxacin—Vomiting—Lisinopril—dilated cardiomyopathy	9.2e-05	0.00085	CcSEcCtD
Ofloxacin—Rash—Lisinopril—dilated cardiomyopathy	9.12e-05	0.000843	CcSEcCtD
Ofloxacin—Dermatitis—Lisinopril—dilated cardiomyopathy	9.12e-05	0.000842	CcSEcCtD
Ofloxacin—Headache—Lisinopril—dilated cardiomyopathy	9.07e-05	0.000838	CcSEcCtD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	8.71e-05	0.00631	CbGpPWpGaD
Ofloxacin—Nausea—Lisinopril—dilated cardiomyopathy	8.6e-05	0.000794	CcSEcCtD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	8.19e-05	0.00593	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	8.17e-05	0.00592	CbGpPWpGaD
Ofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—RAF1—dilated cardiomyopathy	7.95e-05	0.00576	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	7.95e-05	0.00576	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	7.39e-05	0.00535	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	6.76e-05	0.0049	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—TMPO—dilated cardiomyopathy	6.58e-05	0.00476	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	6.52e-05	0.00472	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	6.39e-05	0.00463	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—FAS—dilated cardiomyopathy	6.26e-05	0.00453	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	6.17e-05	0.00447	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	6e-05	0.00435	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	6e-05	0.00435	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	5.97e-05	0.00433	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	5.9e-05	0.00428	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—TMPO—dilated cardiomyopathy	5.88e-05	0.00426	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	5.81e-05	0.00421	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	5.81e-05	0.00421	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	5.74e-05	0.00416	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	5.74e-05	0.00416	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	5.58e-05	0.00404	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	5.57e-05	0.00403	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	5.4e-05	0.00391	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—LMNA—dilated cardiomyopathy	5.4e-05	0.00391	CbGpPWpGaD
Ofloxacin—CYP1A2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	5.35e-05	0.00387	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	5.34e-05	0.00387	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—LMNA—dilated cardiomyopathy	4.83e-05	0.0035	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	4.24e-05	0.00307	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ANKRD1—dilated cardiomyopathy	3.88e-05	0.00281	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—TAZ—dilated cardiomyopathy	3.65e-05	0.00264	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	3.48e-05	0.00252	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	3.31e-05	0.0024	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—SDHA—dilated cardiomyopathy	3.3e-05	0.00239	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	3.11e-05	0.00225	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	2.91e-05	0.0021	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	2.77e-05	0.002	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	2.39e-05	0.00173	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	2.39e-05	0.00173	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	2.27e-05	0.00165	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	2.27e-05	0.00165	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.14e-05	0.00155	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—NPPA—dilated cardiomyopathy	2.02e-05	0.00146	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.01e-05	0.00146	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.96e-05	0.00142	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PSEN2—dilated cardiomyopathy	1.95e-05	0.00141	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.76e-05	0.00128	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.61e-05	0.00117	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	1.47e-05	0.00107	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	1.39e-05	0.001	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	1.25e-05	0.000908	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.22e-05	0.000881	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.18e-05	0.000854	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.16e-05	0.000844	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—RAC1—dilated cardiomyopathy	9.82e-06	0.000711	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GPX1—dilated cardiomyopathy	8.96e-06	0.000649	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CD36—dilated cardiomyopathy	8.73e-06	0.000632	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—AGT—dilated cardiomyopathy	7.86e-06	0.000569	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	7.64e-06	0.000554	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	7.44e-06	0.000539	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	6.7e-06	0.000485	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—RAF1—dilated cardiomyopathy	6.51e-06	0.000472	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—EGFR—dilated cardiomyopathy	4.47e-06	0.000324	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	3.4e-06	0.000247	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	3.31e-06	0.00024	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	2.98e-06	0.000216	CbGpPWpGaD
